MedTrace Logo

A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

NCT03544944 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 297

Last updated 2019-09-04

No results posted yet for this study

Summary

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

Conditions

  • Bowel Preparation

Interventions

DRUG

TJP-008-1

Subjects who are randomized into group TJP-008-1 will receive bowel preparation on the same-day.

DRUG

TJP-008-2

Subjects who are randomized into group TJP-008-2 will receive bowel preparation from evening to next morning.

DRUG

Coolprep powder

Subjects who are randomized into group Coolprep will receive bowel preparation from evening to next morning.

Sponsors & Collaborators

  • Taejoon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2018-05-30
Completion
2018-07-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03544944 on ClinicalTrials.gov